| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ORWE
|
26.90 | 17.9B | 9.00 | 0.97 | 5.00 | 7.0% | 30.3% | 66 | 28 | 34.88 | +21.4% | 78 | 0.43 |
|
KABO
|
9.30 | 5.3B | — | 2.05 | — | — | — | 39 | 32 | 9.13 | -0.9% | 78 | — |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.